A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose

被引:22
作者
Wise, R [1 ]
Andrews, JM [1 ]
Ashby, JP [1 ]
Marshall, J [1 ]
机构
[1] City Hosp NHS Trust, Dept Med Microbiol, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1093/jac/44.5.701
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A single 400 mg oral dose of gatifloxacin was given to each of nine healthy male volunteers and the concentrations of the drug in plasma, cantharidine-induced inflammatory fluid and urine were measured over the following 24 h. The mean peak concentration in plasma of 4.1 mg/L was attained at a mean time of 1.8 h post dose. The mean peak concentration in inflammatory fluid was 3.6 mg/L end was attained at a mean time of 4.2 h post dose. The mean plasma elimination half-life of gatifloxacin was 6.8 h and that in inflammatory fluid was 7.2 h. The mean penetration into the inflammatory fluid was 117%. Recovery of drug from urine during the first 24 h post dose was 65% of that administered. Our data suggest that gatifloxacin dosed at 400 mg od should be adequate to treat systemic infections caused by most bacterial species.
引用
收藏
页码:701 / 704
页数:4
相关论文
共 9 条
[1]   PHARMACOKINETICS AND TISSUE PENETRATION OF THE NEW FLUOROQUINOLONE GREPAFLOXACIN [J].
CHILD, J ;
ANDREWS, JM ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :513-515
[2]  
LORBER S, 1998, 38 INT C ANT AG CHEM, P7
[3]   SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF AM-1155, A NEW 6-FLUORO-8-METHOXY QUINOLONE, IN HUMANS [J].
NAKASHIMA, M ;
UEMATSU, T ;
KOSUGE, K ;
KUSAJIMA, H ;
OOIE, T ;
MASUDA, Y ;
ISHIDA, R ;
UCHIDA, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2635-2640
[4]  
SCHENTAG JJ, 1993, QUINOLONE ANTIMICROB
[5]  
STAHLBERG HJ, 1997, 37 INT C ANT AG CHEM, P14
[6]  
STAHLBERG HJ, 1998, 38 INT C ANT AG CHEM, P8
[7]   IN-VITRO ANTIBACTERIAL ACTIVITY OF AM-1155, A NOVEL 6-FLUORO-8-METHOXY QUINOLONE [J].
WAKABAYASHI, E ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :594-601
[8]   The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones [J].
Wise, R ;
Brenwald, NP ;
Andrews, JM ;
Boswell, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) :447-452
[9]   Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219) [J].
Wise, R ;
Mortiboy, D ;
Child, J ;
Andrews, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :47-49